Compositions and methods for eliciting an immune response to escape mutants of targeted therapies

Details for Australian Patent Application No. 2012216725 (hide)

Owner GlobeImmune, Inc

Inventors Apelian, David; Franzusoff, Alex; Rodell, Timothy C.

Agent FB Rice

Pub. Number AU-A-2012216725

Parent 2006268333

Filing date 7 September 2012

Wipo publication date 4 October 2012

International Classifications

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61K 38/00 Medicinal preparations containing peptides

A61K 39/12 Medicinal preparations containing antigens or antibodies - Viral antigens

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 Antineoplastic agents

Event Publications

27 September 2012 Complete Application Filed

4 October 2012 Application Open to Public Inspection

  Published as AU-A-2012216725

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216726-Oral care implement

2012216724-A mobile showroom and method